The Influence of Remote Hearing Aid Adjustment Technology on the Current Practice of Tele-Audiology among Audiologists in Malaysia.

Objective:  Many hearing aid manufacturers have developed application programs that allow audiologists to fine-tune or adjust their patients' hearing aids remotely. This study aims to explore audiologists' experiences in using the remote hearing aid adjustment in Malaysia.

Method:  This is a qualitative research design where focus group discussions among audiologists were held.

Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity.

Nitrogen bisphosphonates, such as zoledronic acid, target the enzyme farnesyl diphosphate synthase (FDPS) in the isoprenoid biosynthetic pathway (IBP), and are the frontline treatment for osteolytic bone diseases. A strong affinity of these agents for bone limits their distribution out of the skeleton. Geranylgeranyl diphosphate synthase (GGDPS) is directly downstream to FDPS in the IBP and novel GGDPS inhibitors such as RAM2061 have been shown to have key drug-like features including prolonged half-life, metabolic stability, and systemic distribution.

Energy choices to health outcomes: A multidimensional analysis of risk in BRICS via PMG-ARDL approach.

This article employs a Panel Mean Group Autoregressive Distributed Lag (PMG-ARDL) approach to investigate the interaction between carbon dioxide (CO2) emissions, Gross Domestic Product (GDP), fossil fuel, renewable energy consumption, trade, and their collective impact on life expectancy within the BRICS nations. The research reveals compelling findings. Notably, CO2 emissions and trade openness exhibit negative and statistically significant impact on life expectancy.

Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease-The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic.

The epidemiological data regarding mortality rates of adults with sarcoidosis and non-ischemic cardiovascular disease (CVD) are limited. A retrospective observational analysis was conducted to identify trends and disparities related to sarcoidosis and non-ischemic cardiovascular disease mortality among the adult US population from 1999 to 2022. We used the Centers for Disease Control and Prevention (CDC) WONDER database to extract death certificate data for the adult US population (≥25 years).